| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/01/2002 | CA2325088A1 Novel membrane fusion proteins derived from poikilothermic reovirus |
| 05/30/2002 | WO2002042777A2 Modulation of the interaction between evh1 domains |
| 05/30/2002 | WO2002042776A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042772A1 TRIPEPTIDE OF FCηRIIA |
| 05/30/2002 | WO2002042499A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042487A2 Compositions, methods and kits relating to remodelin |
| 05/30/2002 | WO2002042481A1 Paramyxovirus vector encoding angiogenesis gene and utilization thereof |
| 05/30/2002 | WO2002042480A2 Modified vaccinia ankara virus variant |
| 05/30/2002 | WO2002042479A2 Polynucleotides encoding defense response proteins |
| 05/30/2002 | WO2002042467A2 Aspergillus fumigatus profilin |
| 05/30/2002 | WO2002042466A2 Nucleotide sequences coding for the cysq gene |
| 05/30/2002 | WO2002042464A2 Human v2 vomeronasal receptor |
| 05/30/2002 | WO2002042463A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042462A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 05/30/2002 | WO2002042461A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/30/2002 | WO2002042460A2 Compositions and methods relating to colon specific genes and proteins |
| 05/30/2002 | WO2002042459A2 Position dependent recognition of gnn nucleotide triplets by zinc fingers |
| 05/30/2002 | WO2002042458A2 G protein coupled receptors |
| 05/30/2002 | WO2002042457A1 Cloning and expression of human slap-2: a novel sh2/sh3 domain-containing human slap homologue having immune cell-specific expression |
| 05/30/2002 | WO2002042456A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
| 05/30/2002 | WO2002042454A2 Gene involved in schizophrenia |
| 05/30/2002 | WO2002042453A1 A novel polypeptide, a human big protein 0767-19.36 and the polynucleotide encoding the polypeptide |
| 05/30/2002 | WO2002042452A2 Adapter protein and gene encoding it |
| 05/30/2002 | WO2002042451A2 Aspergillus fumigatus cofilin |
| 05/30/2002 | WO2002042448A1 Novel polypeptide |
| 05/30/2002 | WO2002042444A2 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | WO2002042434A1 Cells to be used in producing virus vector, process for producing the same and process for producing virus vector with the use of the cells |
| 05/30/2002 | WO2002042424A2 Seed-preferred regulatory elements and uses thereof |
| 05/30/2002 | WO2002042422A2 Molecular interactions in hematopoietic cells |
| 05/30/2002 | WO2002042420A2 Modulation of gene expression during intimal hyperplasia of the carotid artery |
| 05/30/2002 | WO2002042417A2 Human erg2 potassium channel |
| 05/30/2002 | WO2002042415A2 Agents for blocking t cell mediated immune reactions |
| 05/30/2002 | WO2002042413A2 Methods and compositions involved in groucho-mediated differentiation |
| 05/30/2002 | WO2002042336A2 Fgf-affinity chromatography |
| 05/30/2002 | WO2002042332A2 Truncated cd200 |
| 05/30/2002 | WO2002042331A1 Basic fibroblastic growth factor with a specific collagen binding domain |
| 05/30/2002 | WO2002042330A2 Cystoskeleton-associated proteins |
| 05/30/2002 | WO2002042329A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042328A2 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 05/30/2002 | WO2002042327A2 Cocoa albumin and its use in the production of cocoa and chocolate flavour |
| 05/30/2002 | WO2002042326A1 A method of expression and agents identified thereby |
| 05/30/2002 | WO2002042324A1 Gene encoding protein cluster i and the encoded protein |
| 05/30/2002 | WO2002042323A2 Fluorescent proteins |
| 05/30/2002 | WO2002042322A2 Mammalian nuclear receptor cofactors cf7 and cf8 and methods of use |
| 05/30/2002 | WO2002042321A2 Mixed fibrils |
| 05/30/2002 | WO2002042316A2 Pna analogues |
| 05/30/2002 | WO2002042311A2 Biotin derivatives, methods for making same and uses thereof as vectors |
| 05/30/2002 | WO2002042295A2 Peptides as met-ap2 inhibitors |
| 05/30/2002 | WO2002042118A2 Oil maintenance indicator |
| 05/30/2002 | WO2002041922A1 Method of regulating the activity of expression product of gene transferred into living body |
| 05/30/2002 | WO2002041921A2 Compositions for protection against bovine viral diseases |
| 05/30/2002 | WO2002041913A1 Collectins as adjuvants |
| 05/30/2002 | WO2002041911A2 Use of fgf-19 for inhibiting angiogenesis |
| 05/30/2002 | WO2002041836A2 Antisense modulation of src-1 expression |
| 05/30/2002 | WO2002041763A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 05/30/2002 | WO2002041757A2 Hyaline cartilage replacement substance |
| 05/30/2002 | WO2002041691A2 Transgenic or recombinant non-human mammals and their uses in screening psycho-active medicines |
| 05/30/2002 | WO2002022782A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/30/2002 | WO2002022679A3 Variants of phleum pratense allergenic proteins |
| 05/30/2002 | WO2002022648A3 Compositions and methods for inducing specific cytolytic t cell responses |
| 05/30/2002 | WO2002022633A3 Nucleotide sequences which code for the atr61 gene |
| 05/30/2002 | WO2002020542A3 Nucleotide sequences which code for the gap2 gene |
| 05/30/2002 | WO2002018581A9 G-protein coupled receptors |
| 05/30/2002 | WO2002018441A3 Electroprocessed fibrin-based matrices and tissues |
| 05/30/2002 | WO2002018438A9 Modified proteins, isolated novel peptides, and uses thereof |
| 05/30/2002 | WO2002016579A8 Nucleic acids, vectors, host cells, polypeptides and uses thereof |
| 05/30/2002 | WO2002014496A3 G protein-coupled receptors |
| 05/30/2002 | WO2002014345A3 Antimicrobial peptides isolated from mast cells |
| 05/30/2002 | WO2002012548A8 METHOD OF ANALYZING NFλB ACTIVITY |
| 05/30/2002 | WO2002012328A8 Compositions and methods for the therapy and diagnosis of colon cancer |
| 05/30/2002 | WO2002012277A3 Hybrid combinatorial proteins made from reshuffling of differently folded domains |
| 05/30/2002 | WO2002009643A3 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 05/30/2002 | WO2002008426A3 Fh-binding protein of streptococcus pneumoniae |
| 05/30/2002 | WO2002006477A9 A novel polypeptide-homo topoisomerase 12.1 and polynucleotide encoding said polypeptide |
| 05/30/2002 | WO2002002807A8 Diagnosis of diseases associated with cell signalling |
| 05/30/2002 | WO2002002738A3 Host cells containing multiple integrating vectors |
| 05/30/2002 | WO2002002590A3 I-superfamily conotoxins |
| 05/30/2002 | WO2002000895A3 Bordetella bronchiseptica mutant which produces recombinant pertussis toxin and uses thereof |
| 05/30/2002 | WO2002000723A3 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 05/30/2002 | WO2001096577A8 Production of secreted polypeptides |
| 05/30/2002 | WO2001096396A3 Heliothis glutamate receptor |
| 05/30/2002 | WO2001096364A3 Peptides that stimulate cell survival and axon regeneration |
| 05/30/2002 | WO2001095928A3 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion |
| 05/30/2002 | WO2001094412A3 56201, a novel human sodium ion channel family member and uses thereof |
| 05/30/2002 | WO2001094380A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2001092565A8 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 05/30/2002 | WO2001092333A3 Use of adnf for enhancing learning and memory |
| 05/30/2002 | WO2001092296A3 Regulation of human isotocin-like g protein-coupled receptor |
| 05/30/2002 | WO2001090385A3 IRON REGULATION OF THE PpSEC10 TRANSCRIPTIONAL REGULATORY REGION OF PICHIA PASTORIS AND METHODS OF USE |
| 05/30/2002 | WO2001088139A3 Proteins interacting with a sucrose transporter |
| 05/30/2002 | WO2001087979A3 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| 05/30/2002 | WO2001087978A3 Human abc transporter and its use |
| 05/30/2002 | WO2001087934A3 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides |
| 05/30/2002 | WO2001087929A3 Regulation of human dopamine-like g protein-coupled receptor |
| 05/30/2002 | WO2001087919A3 Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins |
| 05/30/2002 | WO2001087330A3 Compositions and methods for achieving immune suppression |
| 05/30/2002 | WO2001085931A3 Polypeptide inhibiting a proton-gated na+ channel |
| 05/30/2002 | WO2001083561A3 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses |
| 05/30/2002 | WO2001081413A3 Isolated human transporter proteins, nucleic acids and uses thereof |